Erratum to: npj Regen Med (2017); doi:10.1038/s41536-017-0015-2; Published 07 April 2017
This Review Article contains typographical errors in the ‘Novel strategies to restore myocardial electrical conduction’ section under subheading ‘Gene therapies to treat arrhythmias’.
“Ex vivo optical mapping performed on whole rat hearts (both healthy or with MI) showed that patches reduced cardiac conduction velocities when applied on the epicardium. Thus, although patches exerted a negative effect on cardiac electrical integrity, they were successful in altering the electrophysiological properties of the tissue.”
Should read:
“Ex vivo optical mapping performed on whole rat hearts showed that patches reduced cardiac conduction velocities when applied on the epicardium of healthy hearts but increased in a heart with MI. Thus, patches were successful in altering the electrophysiological properties of the tissue.”
This Review Article also contains errors in Table 1. The correct Table 1 appears below as Table 1.
Table 1.
Material | Refs. | Scaffold | Elastic modulus (kPa)/ Conductivity (S/m) | Cell source | Main results |
---|---|---|---|---|---|
Gold | [100] | AuNW-incorporated alginate scaffolds | ~3.5/n.a. | Neonatal CM | Thick and aligned cell constructs; ↑ α-SA and Cx43; synchronous contractions |
[117] | AuNP-deposited PCL fibers | ~60 × 103/n.a. | Neonatal CM | Elongated CM, aligned and striated cell constructs; ↑ contraction rate and force | |
[103] | AuNP-incorporated biodegradable PU scaffolds | ~200–240/n.a. | H9C2 | Improved cell spreading and alignment; ↑ Nkx2.5, ANF, NPPB expression | |
[118] | AuNP-deposited PCL/gelatin scaffolds | n.a./n.a. | Neonatal CM | Elongated CM, visible striation and ↑ aspect ratio; ↑ contraction amplitudes and rates | |
[101] | AuNP-deposited decellularized pig omental matrices | ~12.5 × 103/n.a. | Neonatal CM | Elongated CM, aligned and striated cell constructs; Cx43 between adjacent CM; ↑ contraction amplitude, calcium transient propagation velocity; ↓ excitation threshold | |
[119] | AuNP-deposited thiol-HEMA/HEMA scaffolds | ~600–1600/~11–15 | Neonatal CM | CM presented as clusters or single cells; 2-fold ↑ Cx43 protein levels | |
[120] | AuNW-incorporated GelMA hydrogels | ~1.3/n.a. | Neonatal CM | ↑ cell retention and viability; highly organized sarcomeric structures; ↑ beating frequency; more synchronous, stable, and robust beating behavior; synchronized calcium transients; ↓ excitation threshold | |
Carbon | [106] | MWCNT-embedded PG nanofibers | ~373.5/n.a. | Neonatal CM | ↑ CM alignment, metabolic activity and viability; ↑ Cx43 staining |
[104, 105] | MWCNT solution coating a glass substrate | n.a./n.a. | Neonatal CM | ↑ metabolic activity; more negative membrane resting potential; ↑ αMHC, SERCA2a, Cx43; ↓ ANF | |
[121] | Chitosan:CNTs composite scaffolds | ~28.1/~0.25 (hydrated) | Neonatal CM | ↑ CM alignment and metabolic activity; ↑ TnI, SERCA2a, GATA4, αMHC, Cx43, βMHC and ANF expression | |
[107] | SWCNT-incorporated gelatin-chitosan hydrogels | ~19.3 (175 p.p.m.)/n.a. | Neonatal CM | Concentration-dependent cytotoxicity; more developed sarcomeres; ↑ α-SA; intercellular Cx43 staining; ↑ beating rates and conduction velocity; ↓ AP duration | |
[122] | CNT-embedded GelMA hydrogels | ~20–54/n.a. | Neonatal CM | Aligned, interconnected CM; developed sarcomeres; attenuation of heptanol-induced intercellular coupling inhibition | |
[123] | PLGA:CNFs composite substrates | n.a./~5 × 10-4–7 × 10−3 | Human CM, rat EC, NIH/3T3 | ↑ CM density; ↓ ECs and fibroblast growth | |
[109] | SWCNT/collagen solution coating a glass substrate | n.a./~1.90 × 10-8–1.77 × 103 | Neonatal CM | Marked striation and organized sarcomeres; functional beating syncytium; ↑TnI, Cx43, N-cadherin, plakophilin2 and plakoglobin expression; well-developed intercalated disc junctions; ↑ β1-integrin, FAK, p-ERK, MEF-2c and GATA4 | |
[108] | SWCNT-incorporated gelatin hydrogels | n.a. (shear modulus:~20–400 Pa)/~5 × 10−5 | Neonatal CM | In vitro: aligned cell constructs; organized sarcomeres; ↑ α-SA and Cx43 levels; spontaneous electrical activity; In vivo (MI rats): ↑ Cx43, NaV1.5 and N-cadherin protein levels; unclear scaffold/scar boundary; presence of smooth-muscle cells and CD68+ macrophages; ↑ ejection fraction and fractional shortening. Electrical coupling was assessed by evaluating Cx43 | |
Conductive polymers | [111] | PCL/PU blend scaffolds containing aniline pentamers | ~1.3 × 103/~10-4–104 | Neonatal CM | ↑ TnT, Cx43, actinin-α-4 |
[110] | Nanofibrous 2D meshes of HCl-doped PANI/PLGA blend | ~91.7 × 103/~0.31 | Neonatal CM | Isolated cell clusters; spontaneous beating activity; ↑ TnI, Cx43 expression; intercellular Cx43 localization | |
[112] | PPy/PCL/gelatin blend nanofibers on glass substrate | ~16.8 × 103/~1.3 × 10−3 | Rabbit CM | ↑ α-SA, TnT and Cx43; increasing PPy proportion disrupted mechanical properties and slowed CM growth | |
[114] | Injectable PPy-grafted chitosan hydrogel | ~2/~0.02 | Neonatal CM | In vitro: ↑ Ca2+ transients velocity;In vivo (MI rats): QRS interval duration similar to healthy; ↑ transverse and border zone/scar region conduction velocities; ↑ ejection fraction, dP/dt max and min, preload recruitable stroke work; Note: although ex vivo optical mapping was performed to assess conduction velocities at the injection site, since the hydrogel was injected without cells, electrical coupling between implanted cells and the native myocardium was not evaluated | |
[113] | Films of interpenetrating PPy and PCL networks | ~9.3 × 105/~0.10 | HL-1 | ↑ proportion of cells with peripheral Cx43 expression;↑ Ca2+ transients velocity and spontaneous electrical activity frequency | |
[115] | Films of chitosan and PANI | ~6.7 × 103/~16 | n.a. | Ex vivo: rat cardiac slices-↓ transverse and longitudinal conduction velocities; Whole rat hearts (optical mapping) - ↓ conduction velocities on healthy hearts and ↑ on MI hearts.In vivo (healthy rats): unaffected ejection fraction, fractional shortening and no aggravated arrhythmia inducibility | |
Silicon | [116] | SiNW-incorporated cardiac cell spheroids | n.a./150–500 | Neonatal CMs or hiPSC-derived CMs | Improved intercellular coupling (e.g., ↑ Cx43 and N-cadherin); improved contractile machinery development; ↑ β-MHC/α-MHC ratio; ↓ spontaneous beating frequency |
n.a. non-available, αMHC alpha myosin heavy chain, α-SA alpha-sarcomericactinin, βMHC beta myosin heavy chain. ANF atrial natriuretic factor, AuNP gold nanoparticle, AuNW gold nanowire, CM cardiomyocyte, CNT carbon nanotube, CNF carbon nanofibers, Cx43 connexin-43, EC endothelial cell, ERK extracellular-signal-regulated kinase, ESC embryonic stem cell, FAK focal adhesion kinase, GelMA gelatin methacrylate, HEMA hydroxyethylmethacrylate, hiPSCs human-induced pluripotent stem cells, MEF-2c myocyte-specific enhancer factor 2C, MHC myosin heavy chain, MI myocardial infarction, MWCNT multi-walled carbon nanotube, NPPB natriuretic peptide precursor B, PANI polyaniline, PCL polycaprolactone, PECAM1 platelet endothelial cell adhesion molecule 1, PLGA polylactic-co-glycolic acid, PPy polypyrrole, PU polyurethane, SERCA2a sarcoplasmic reticulum Ca2+ ATPase 2a, SiNW silicon nanowire, SWCNT single-walled carbon nanotube, TnI troponin I, TnT troponin
Footnotes
The online version of the original article can be found at http://dx.doi.org/10.1038/s41536-017-0015-2.